Alba Sanz Sanjuan, Dr. Danielle Clancy, and Prof. Savvas Savvides

Scientists reveal how developing immune cells fine-tune their signals

Ghent, 27 May 2026 - Researchers at VIB, Ghent University, and VUB have uncovered how two proteins essential for immune cell development work together at the molecular level. The findings provide important insights into a critical mechanism that mediates the integration of molecular signals received from immunological threats. Their work appears in Nature Communications.

Solving a long-standing mystery in T cell biology

T cells undergo a strict selection process in the thymus before they become fully functional. This ensures that healthy T cells can recognize immunological threats while avoiding attacks against the body’s own tissues. Dysregulation of this process can contribute to autoimmune diseases or immune deficiencies.

For nearly two decades, scientists have known that a protein called Themis is essential for this developmental checkpoint. However, exactly how Themis worked at the molecular level remained unclear.

“Themis has always been something of an enigma,” says Dr. Danielle Clancy (VIB-UGent Center for Inflammation Research), first author of the study. “We knew it played a critical role in T cell development, but we lacked a structural understanding of how it interacts with signaling partners to carry out its function.”

The new study reveals, for the first time, the three-dimensional structure of Themis bound to Grb2, a multifunctional protein involved in numerous signaling pathways inside cells.

A dynamic signaling hub

Using cryo-electron microscopy, the researchers discovered that Themis wraps around Grb2 in an unexpectedly intricate way. At the same time, part of Grb2 remains flexible, allowing the complex to recruit other signaling proteins when T cells are activated.

Illustration of how the Themis-Grb2 complex affects T cell development.
“What surprised us most was how extensively Themis embraces Grb2,” explains Prof. Savvas Savvides (VIB-UGent), senior author of the study.
“The interaction is much more sophisticated than anyone anticipated, involving multiple cooperative contact points that stabilize the resulting constitutive complex”, adds Clancy.

The team also showed that disrupting this interaction interferes with important signaling events, confirming that the Themis-Grb2 complex is essential for proper T cell development. ​

 

“Our work provides a structural blueprint for a key signaling hub in the immune system,” say Clancy and ​ Savvides. “These insights will help us better understand how immune cells develop and may eventually support new approaches for treating immune-related diseases.”

Publication

Structural and mechanistic insights into the constitutive Themis-Grb2 complex in T cell signaling. Clancy, et al. Nature Communications, 2026. DOI: 10.1038/s41467-026-73359-8

Funding

This work was supported by Research Foundation Flanders – FWO and VIB.


Kristof Windels

Media Relations Manager, VIB
Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

Share

Latest stories

Website preview
Rainbow Crops raises €9.7M seed round to scale AI-driven multiplex gene editing for next-generation crops
The round was led by Italian venture capital company LIFTT, together with its vehicle LIFTT EuroInvest
press.vib.be
Website preview
Researchers identify a key biological tipping point in Alzheimer’s disease
Leuven, 4 June 2026 – Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer’s disease pathology leads to dementia. Studying brain tissue from older adults with and without cognitive decline, as well as cognitively healthy centenarians, the team identified distinct cellular programs and immune-cell states associated with disease progression and resilience. Their findings, published in Nature Medicine, suggest that changes in microglia—the brain’s resident immune cells—could represent an important target for future Alzheimer’s therapies.
press.vib.be
Website preview
Prof. Diether Lambrechts (KU Leuven/VIB) receives the Francqui-Collen Prize 2026
Brussels, June 2, 2026 – Prof. Dr. Diether Lambrechts (KU Leuven/VIB) and Prof. Dr. Patrice Cani (UCLouvain) are the laureates of the Francqui-Collen Prize 2026, one of the highest scientific distinctions in Belgium. Today, they receive the award from the hands of King Philippe. Prof. Lambrechts is being honored for his groundbreaking genetic research into cancer treatments, while Prof. Cani is recognized for his discoveries regarding the impact of gut bacteria on lifestyle-related diseases.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be